• Braze, Inc. recently appointed Pearce Dolan as Chief Product Officer, bringing nearly 20 years of product and technology leadership experience from roles at Deel and Revolut to oversee product strategy under CEO Bill Magnuson.
• The hire underscores Braze’s focus on advancing AI-driven customer engagement, adding a leader with a track record of scaling complex, multi-product platforms across HR, fintech, and payroll services.
• Next, we’ll examine how Dolan’s AI-focused product leadership could influence Braze’s existing investment narrative around AI-enabled customer engagement.

Find 46 companies with promising cash flow potential yet trading below their fair value.

Braze Investment Narrative Recap

To own Braze, you need to believe that AI-enabled customer engagement can support a differentiated, subscription-based software business despite ongoing losses. In the near term, the key catalyst is adoption of Braze’s new AI products, while the biggest risk is execution and cost pressure around integrating OfferFit and scaling complex deployments. Dolan’s appointment as CPO appears directionally aligned with the AI story, but does not, on its own, materially change those near-term risks or catalysts.

The most relevant recent announcement alongside Dolan’s hire is Braze’s April 2026 rollout of BrazeAI Operator, Agent Console, and Decisioning Studio. These products sit at the heart of the AI narrative Dolan is stepping into, and their real-world usage could be a meaningful driver of deal expansion and differentiation. At the same time, they increase product complexity, which could magnify the existing risk around implementation costs and the need for sophisticated client setups.

Yet behind the AI opportunity, investors should be aware that rising product complexity and competition could still...

Braze's narrative projects $1.2 billion revenue and $149.3 million earnings by 2029. This requires 16.1% yearly revenue growth and a $271.4 million earnings increase from -$122.1 million today.

Uncover how Braze's forecasts yield a $34.40 fair value, in line with its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were far more cautious, assuming about 17.8% annual revenue growth and no profitability by 2029, and warning that rising product complexity and AI commoditization could pressure pricing power, so Dolan’s appointment may eventually shift how you weigh those concerns against the more optimistic AI integration story.

Explore 5 other fair value estimates on Braze - why the stock might be a potential multi-bagger!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Braze research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Braze research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Braze's overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.